Skip to content

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Using Combination of Albumin to Globulin Ratio and Prognostic Nutritional Index Model for Predicting Disease Activity in Patients With Systemic Lupus Erythematosus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07043153
Enrollment
200
Registered
2025-06-29
Start date
2025-08-05
Completion date
2026-06-01
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus Disease

Brief summary

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Interventions

DIAGNOSTIC_TESTAlbumin to globulin ratio and prognostic nutritional index model

Measurement of albumin to globulin ratio and prognostic nutritional index in participants to assess disease activity in systemic lupus erythematosus patients

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* · Age ≥ 18 years. * Both sexes. * Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls.

Exclusion criteria

* Co-existing chronic inflammatory or autoimmune diseases. * Age \<18 years * Malignancy. * Pregnancy or lactation. * Chronic liver or renal insufficiency. * Malignant hematologic diseases. * Active hepatitis. * Acute infection within the previous four weeks

Design outcomes

Primary

MeasureTime frame
assess the utility of the albumin-to-globulin ratio (AGR) as reliable, non-invasive biomarker for predicting disease activity in patients with systemic lupus erythematosus (SLE).From 6 month to one year

Countries

Egypt

Contacts

CONTACTHala A Hamid, Master
Hala.hamed@med.sohag.edu.eg20 01122385665
CONTACTEsam M Abualfadl, Professor
20 01125677779
STUDY_CHAIREsam M Abualfadl, Professor

Sohag University

STUDY_DIRECTORRabab H Ali, MD

Sohag University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026